Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Chin Med Sci J ; 28(3): 129-34, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24074613

RESUMEN

OBJECTIVE: To investigate trichorhinophalangeal syndrome 1 gene (TRPS-1) expression patterns in different subtypes of breast cancer and its correlations with other genes and survival using microarray data sets. METHODS: The transcripts of TRPS-1 and its role in survival in breast cancer were analyzed using published microarray data sets#x02014;Netherlands Cancer Institute (NKI) cohort and Wang cohort. RESULTS: TRPS-1 expression was lower in basal-like breast cancer. The mRNA levels of TRPS-1 negatively correlated with Slug (Pearson correlation coefficient=-0.1366, P=0.0189 in NKI data set and Pearson correlation coefficient=-0.1571, P=0.0078 in Wang data set), FOXC1 (Pearson correlation coefficient=-0.1211, P=0.0376 in NKI data set and Pearson correlation coefficient=-0.1709, P=0.0037 in Wang data set), and CXCL1 (Pearson correlation coefficient=-0.1197, P=0.0399 in NKI data set and Pearson correlation coefficient=-0.3436, P<0.0001 in Wang data set), but positively correlated with BRCA1 (Pearson correlation coefficient=0.1728, P=0.0029 in NKI data set and Pearson correlation coefficient=0.1805, P=0.0022 in Wang data set). Low TRPS-1 expression associated with poor overall survival (hazard ratio 1.79, 95% CI of ratio 0.9894 to 3.238, P=0.054) and relapse-free survival (hazard ratio 1.913, 95% CI of ratio 1.159 to 3.156, P<0.05). The low TRPS-1 mRNA levels predicted poor outcome in breast cancer patients by the 70-gene signature. CONCLUSION: The strong expression of TRPS-1 may serve as a good prognostic marker in breast cancer.


Asunto(s)
Biomarcadores de Tumor/biosíntesis , Neoplasias de la Mama , Proteínas de Unión al ADN/biosíntesis , Transición Epitelial-Mesenquimal , Regulación Neoplásica de la Expresión Génica , Proteínas de Neoplasias/biosíntesis , ARN Mensajero/biosíntesis , ARN Neoplásico/biosíntesis , Factores de Transcripción/biosíntesis , Adulto , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Línea Celular Tumoral , Estudios de Cohortes , Supervivencia sin Enfermedad , Femenino , Humanos , Persona de Mediana Edad , Proteínas Represoras , Tasa de Supervivencia
2.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 41(2): 125-31, 2012 03.
Artículo en Zh | MEDLINE | ID: mdl-22499507

RESUMEN

OBJECTIVE: To investigate the effect of maternal deprivation on the activity of hypothalamo-pituitary-adrenal (HPA) axis, acute stress response and the sex hormone receptors expression in hypothalamic paraventricular nucleus (PVN) in female rats. METHODS: Maternal deprivation model was induced in female Sprague-Dawley (SD) rats. Foot shock was given at different stages of estrus cycle during the adulthood. Plasma estradiol, testosterone and adrenocorticotropin (ACTH) levels were determined by radioimmunoassay; and plasma corticosterone level was measured by enzyme linked immunosorbent assay. The expression of androgen receptor (AR) and estrogen receptor (ER-ß) in the hypothalamic PVN was detected by immunohistochemistry. RESULTS: Decreased plasma ACTH and corticosterone levels were found in the proestrus of female rats with maternal deprivation (P=0.012 and P=0.019, respectively). A significant down-regulation (P=0.008) of PVN-AR, but not PVN-ER-ß expression was found in female rats with maternal deprivation. CONCLUSION: Maternal deprivation may reduce the HPA axis activity in female SD rats, which is closely correlated with the fluctuation of the circulating sex hormones. The androgen in the hypothalamus seems to play a more important role than the estrogen in this procedure.


Asunto(s)
Sistema Hipotálamo-Hipofisario/fisiopatología , Privación Materna , Sistema Hipófiso-Suprarrenal/fisiopatología , Estrés Fisiológico , Hormona Adrenocorticotrópica/sangre , Animales , Corticosterona/sangre , Estradiol/sangre , Femenino , Núcleo Hipotalámico Paraventricular/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores Androgénicos/metabolismo , Receptores de Estrógenos/metabolismo , Testosterona/sangre
3.
Gastroenterol Res Pract ; 2018: 9187316, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30622563

RESUMEN

Hepatitis B virus (HBV) infection is a major risk factor for the development of hepatic cirrhosis (HC) and hepatocellular carcinoma (HCC), which are associated with very high morbidity and mortality rates worldwide. Many studies have shown that long noncoding RNAs (lncRNAs) that are highly expressed in HCC (lncRNA-HEIH) and highly upregulated in liver cancer (lncRNA-HULC) have been implicated in the development and progression of hepatitis B-related HC and HCC. In this study, reverse transcription and quantitative PCR were used to detect the expression of lncRNA-HEIH and lncRNA-HULC and western blot analysis to detect the expression of hepatitis B X-interacting protein (HBXIP). RNA immunoprecipitation was used to detect the interaction of HBXIP with lncRNA-HULC and lncRNA-HEIH. The results showed that lncRNA-HEIH, lncRNA-HULC, and HBXIP were upregulated in hepatitis B patients, particularly those with hepatitis B-related HCC. Both lncRNA-HEIH and lncRNA-HULC interacted with HBXIP. These results suggest that lncRNA-HEIH and lncRNA-HULC interact with HBXIP in hepatitis B-related diseases.

4.
Cancer Lett ; 253(1): 60-7, 2007 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-17379400

RESUMEN

We detected aberrant Midkine (MK) expressions in human insulinoma and pancreatic cancer tissues by immunohistochemistry, revealing its potential role in tumorigenesis/carcinogenesis. With a nested-touchdown PCR program we were able to detect the tMK in all human tumor/cancer tissues and cancer/tumor cell lines. Detection of MK in the peripheral cells and precancerous lesions implies its potential for early cancer/tumor diagnosis. Furthermore, we have discovered two novel truncations of the MK, tMKB and tMKC, respectively, in the disease specimens. Our data not only provide an efficient methodology potentially for clinical application but also shed light on the molecular mechanism underlying the role for MK in tumorigenesis/carcinogenesis.


Asunto(s)
Citocinas/genética , Insulinoma/genética , Neoplasias Pancreáticas/genética , Adulto , Secuencia de Aminoácidos , Línea Celular Tumoral , Citocinas/metabolismo , Humanos , Insulinoma/metabolismo , Midkina , Datos de Secuencia Molecular , Mutación , Páncreas/metabolismo , Neoplasias Pancreáticas/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
5.
Mol Med Rep ; 11(3): 2322-8, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25384365

RESUMEN

Obesity is associated with numerous immunological disorders. The present study investigated the proportion and phenotype of myeloid­derived suppressor cells (MDSCs) in the plasma of obese subjects and the association of these cells with the level of liver enzymes. Certain features of the immune response in obese subjects were examined by analyzing the expression of T cell receptor­Î¶ (TCRζ) molecules on the surface of T cells. The expression and secretion of S100A9, a possible marker for MDSCs, were detected in the peripheral blood of obese subjects and compared with levels in lean controls. Results showed that the percentage of monocytic MDSCs, with the phenotype CD33+CD11b+CD14+HLADRlow/­, was significantly increased in obese subjects compared with lean controls. The circulating level of monocytic MDSCs was positively correlated with the levels of liver enzymes in serum. The expression of the TCRζ molecule in the resting T cells was significantly lower in obese individuals than that of lean controls. The expression of S100A9 was detected in the majority of monocytes in peripheral blood mononulear cells, but no difference was identified in the frequency of CD14+S100A9+ cells between the obese and lean groups. However, the plasma level of S100A8/9 was significantly increased in obese compared with lean subjects. These observations suggested that the increased frequency of CD33+CD11b+CD14+HLADRlow/­ cells may be responsible for the impaired T­cell function and liver injury observed in obesity.


Asunto(s)
Antígenos HLA-DR/metabolismo , Receptores de Lipopolisacáridos/metabolismo , Células Mieloides/metabolismo , Obesidad/metabolismo , Adulto , Calgranulina B/sangre , Calgranulina B/genética , Calgranulina B/metabolismo , Estudios de Casos y Controles , Humanos , Inmunofenotipificación , Recuento de Leucocitos , Leucocitos Mononucleares/metabolismo , Pruebas de Función Hepática , Masculino , Monocitos/metabolismo , Obesidad/diagnóstico por imagen , Fenotipo , Receptores de Antígenos de Linfocitos T gamma-delta/metabolismo , Ultrasonografía
6.
Biochem Biophys Res Commun ; 359(3): 491-6, 2007 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-17559809

RESUMEN

The oscillations of circadian genes control the daily circadian clock, regulating a diverse array of physiologies with the 24-hour light/dark cue across a wide variety of organisms. Here we first show that before embryonic circadian rhythms occur, the oscillation (nucleocytoplasmic shuttling) of core circadian gene Clock is tissue-specific and correlated with the state of differentiation during both early development and later pancreas organogenesis. Disruption of Clock as well as Timeless in the embryonic pancreas does not block pancreatic differentiation but alters the balance and maturity of endocrine and exocrine cells. Molecular analysis indicates that inhibition of Clock or Timeless expression disturbs not only cell cycle regulators, but also Wnt- and Notch-signaling components, whose oscillations establish the timing mechanism in somitogenesis. Thus, our results provide new insights about circadian genes' function in control of the timing of differentiation during embryonic development.


Asunto(s)
Diferenciación Celular , Ritmo Circadiano/fisiología , Páncreas/citología , Páncreas/metabolismo , Receptores Notch/metabolismo , Transactivadores/metabolismo , Proteínas Wnt/metabolismo , Animales , Proteínas CLOCK , División Celular , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Ratones , Oligonucleótidos Antisentido/genética , Páncreas/embriología , Receptores Notch/genética , Factores de Tiempo , Transactivadores/genética , Factores de Transcripción/metabolismo , Proteínas Wnt/genética
7.
J Biol Chem ; 280(40): 33819-25, 2005 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-16093243

RESUMEN

Protein Z-dependent protease inhibitor (ZPI) is a serpin inhibitor of coagulation factor (F) Xa dependent on protein Z, Ca2+, and phospholipids. In new studies, ZPI inhibited FIXa in the FXase complex. Since this observation could merely represent inhibition of the FXa product whose activity was measured, inhibition of FIXa was investigated five ways. 1) FXase incubation mixtures with/without ZPI/protein Z were diluted in EDTA; FXa activity was measured after reversal of its inhibition. 2) FXase incubation mixtures were immunoblotted for FXa product. 3) FX activation peptide region was 3H-labeled; release of 3H was used to measure FXase activity. 4) Activity was monitored in a FIXa-based clotting assay. 5) FIXa amidolytic activity was measured. In all cases, FIXa was inhibited by subphysiologic levels of ZPI. Unlike inhibition of FXa, inhibition of FIXa did not strictly require protein Z. Low concentrations of FVIIIa increased the efficiency of ZPI inhibition of FIXa; FVIIIa in molar excess was not protective of FIXa unless FIXa/FVIIIa interacted prior to ZPI exposure. Unusual time courses were observed for inhibition of both FIXa in the FXase complex and FXa in the prothrombinase complex. Activity loss stabilized in <100 s at a level dependent on ZPI concentration, suggesting equilibrium interactions rather than typical covalent serpin-protease interactions. Surface plasmon resonance binding experiments revealed binding and dissociation of ZPI/FIXa with Kd (app) of 9-12 nm, similar to the concentration of ZPI needed for 50% inhibition. ZPI may be an unusual physiologic regulator of both the intrinsic FXase and the prothrombinase complexes.


Asunto(s)
Factor IXa/biosíntesis , Serpinas/metabolismo , Factores de Coagulación Sanguínea/metabolismo , Cisteína Endopeptidasas/metabolismo , Regulación hacia Abajo , Inhibidores Enzimáticos/farmacología , Factor IXa/genética , Humanos , Immunoblotting , Cinética , Proteínas de Neoplasias/metabolismo , Proteínas Recombinantes , Tromboplastina/metabolismo
8.
Biochem Biophys Res Commun ; 330(4): 1230-6, 2005 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-15823575

RESUMEN

Midkine (MK) is a retinoic acid response cytokine, mostly expressed in embryonic tissues. Aberrant expression of MK was found in numerous cancers. In human, a truncated MK was expressed specifically in tumor/cancer tissues. Here we report the discovery of a novel truncated form of MK transiently expressed during normal mouse embryonic development. In addition, MK is concentrated at the interface between developing epithelium and mesenchyme as well as highly proliferating cells. Its expression, which is closely coordinated with angiogenesis and vasculogenesis, is spatiotemporally regulated with peaks in extensive organogenesis period and undifferentiated cells tailing off in maturing cells, implying its role in nascent blood vessel (endothelial) signaling of tissue differentiation and stem cell renewal/differentiation. Cloning and sequencing analysis revealed that the embryonic truncated MK, in which the conserved domain is in-frame deleted, presumably producing a novel secreted small peptide, is different from the truncated form in human cancer tissues, whose deletion results in a frame-shift mutation. Our data suggest that MK may play a role in epithelium-mesenchyme interactions, blood vessel signaling, and the decision of proliferation vs differentiation. Detection of the transiently expressed truncated MK reveals its novel function in development and sheds light on its role in carcinogenesis.


Asunto(s)
Diferenciación Celular/fisiología , Citocinas/biosíntesis , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Vasos Sanguíneos/embriología , Proliferación Celular , Citocinas/genética , Epitelio/embriología , Epitelio/metabolismo , Regulación del Desarrollo de la Expresión Génica , Humanos , Inmunohistoquímica , Mesodermo/citología , Mesodermo/metabolismo , Ratones , Midkina , Datos de Secuencia Molecular , Mutación , Especificidad de Órganos , Células Madre/citología , Células Madre/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA